Filtered By:
Nutrition: Calcium
This page shows you your search results in order of relevance. This is page number 17.
Order by Relevance | Date
Total 42677 results found since Jan 2013.
A neonate with late-onset hypocalcemia due to unrecognized maternal hyperparathyroidism and a systematic overview of similar cases
Conclusion: This is one of the few cases in the literature where neonatal symptomatology led to the diagnosis of undiagnosed maternal hyperparathyroidism. Early detection and appropriate management of neonatal hypocalcemia could eliminate serious maternal and fetal morbidity.PMID:34539299 | PMC:PMC8422796 | DOI:10.3205/000296
Source: GMS German Medical Science - September 20, 2021 Category: General Medicine Authors: Georgios Mitsiakos Georgios N Katsaras Ilias Chatziioannidis Anastasia Gkampeta Christina Mitsiakou Nikolaos Nikolaidis Source Type: research
A meta-analysis of the therapeutic effect of intranasal salmon calcitonin on osteoporosis
ConclusionThe intranasal salmon calcitonin is superior to conventional drugs in reducing blood calcium, increasing creatinine ratio, and alkaline phosphatase, but its advantages in other indicators such as improving the bone mineral density (BMD) of lumbar vertebrae and hip have not been confirmed, and it is not clear that the combination of intranasal salmon calcitonin and other conventional drugs is better than the simple conventional drugs.
Source: European Journal of Medical Research - December 8, 2021 Category: Research Source Type: research
A systematic review of the pharmacotherapy of secondary hyperparathyroidism (SHPT) in grades 3-5 Chronic Kidney Disease (CKD)
CONCLUSIONS: Calcifediol ER, paricalcitol, and cinacalcet significantly decreased the iPTH level in the patients under study. Paricalcitol increased the serum calcium concentration the most of all the drugs under analysis. It is noteworthy that only cinacalcet does not carry the risk of hypercalcemia.PMID:35049000 | DOI:10.26355/eurrev_202201_27773
Source: European Review for Medical and Pharmacological Sciences - January 20, 2022 Category: Drugs & Pharmacology Authors: M Miedziaszczyk I Idasiak-Piechocka O W Wi śniewski K Lacka Source Type: research
A Discrepancy: Calcium Channel Blockers are Effective for the Treatment of Hypertensive Left Ventricular Hypertrophy but Not as Effective for Prevention of Heart Failure
Conclusion. CCBs are somewhat inferior to renin-angiotensin-aldosterone system blockers but still very good in HTN LVH regression; consequently, CCBs are expected to protect from HF. On the contrary, CCBs protect from HF less than other first-line antihypertensive drugs. This discrepancy needs a clear explanation in order to improve clinical practice.
Source: Medical Principles and Practice - August 31, 2022 Category: Internal Medicine Source Type: research
